Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$209.01 - $232.56 $2.84 Million - $3.16 Million
13,580 New
13,580 $2.97 Billion
Q3 2023

Aug 14, 2024

SELL
$201.05 - $221.7 $50,664 - $55,868
-252 Reduced 31.07%
559 $112 Million
Q2 2023

Aug 14, 2024

SELL
$211.93 - $241.33 $775,239 - $882,785
-3,658 Reduced 81.85%
811 $196 Million
Q1 2023

Aug 14, 2024

SELL
$213.32 - $257.83 $1.25 Million - $1.5 Million
-5,837 Reduced 56.64%
4,469 $1.03 Billion
Q3 2022

Aug 14, 2024

BUY
$204.81 - $262.19 $58,166 - $74,461
284 Added 2.83%
10,306 $2.11 Billion
Q2 2022

Aug 14, 2024

BUY
$213.86 - $277.87 $531,442 - $690,506
2,485 Added 32.97%
10,022 $2.35 Billion
Q1 2022

Aug 14, 2024

BUY
$259.82 - $298.18 $1.96 Million - $2.25 Million
7,537 New
7,537 $1.99 Billion
Q4 2021

Aug 30, 2024

BUY
$271.6 - $314.21 $215,922 - $249,796
795 Added 12.45%
7,181 $2.25 Billion
Q3 2021

Aug 30, 2024

SELL
$274.82 - $308.34 $24,184 - $27,133
-88 Reduced 1.36%
6,386 $1.8 Billion
Q2 2021

Aug 30, 2024

BUY
$251.87 - $278.14 $1.63 Million - $1.8 Million
6,474 New
6,474 $1.78 Billion
Q1 2021

Aug 30, 2024

BUY
$204.88 - $255.03 $1.11 Million - $1.38 Million
5,399 Added 498.52%
6,482 $1.65 Billion
Q4 2020

Aug 30, 2024

BUY
$186.91 - $214.42 $202,423 - $232,216
1,083 New
1,083 $221 Million
Q2 2019

Aug 30, 2024

SELL
$144.16 - $172.9 $14,416 - $17,290
-100 Closed
0 $0
Q1 2019

Aug 30, 2024

BUY
$123.7 - $156.3 $12,370 - $15,630
100 New
100 $15.3 Million
Q2 2018

Aug 30, 2024

SELL
$160.33 - $189.41 $1,442 - $1,704
-9 Closed
0 $0
Q3 2017

Aug 30, 2024

SELL
$149.47 - $160.56 $40,356 - $43,351
-270 Reduced 96.77%
9 $1.36 Million
Q2 2017

Aug 30, 2024

BUY
N/A
279
279 $43 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.